Nuvation Bio: Pending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst
Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...
STAT4d
The biggest biotech news stories from the weekend
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...
U.S. Biomedical Leadership Threatened By NIH Licensing Guidelines
New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...
Daily Trojan2d
Dornsife partners with biotech company to host first-ever ‘BioFestival’
Sam Finn, a senior research associate at Zymo Research working with the Oncology Diagnostic Team, helped to host this interactive game booth at the “BioFestival” on Tuesday.
BioSpace1d
Vir Leans Into Immunology Roots After Flamed-Out COVID Fame
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
stockhead on MSN2d
ASX healthcare leaders wear many hats in interconnected sector
In the interconnected ASX healthcare sector it can be common for leaders to be involved in multiple companies and ...
Technical6d
From Belgaum to Baltimore and beyond, this founder leaned on family to build a biotech juggernaut
An immigrant entrepreneur, Andrea Pais cofounded Novel Microdevices by figuring it out as she went along — and learning where to find support.
Titan Partners Announces Launch of Equity Research Division, Appoints Boris Peaker as Senior Healthcare Analyst
Ryan Konik, Co-Founder and Partner at Titan, added, "Dr. Peaker's technical background, combined with his sell-side research experience, makes him an exceptional fit for our platform. His addition ...